Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 5
2002 18
2003 16
2004 6
2005 2
2007 4
2008 3
2011 1
2013 2
2014 1
2015 1
2018 2
2019 2
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
Arrieta AC, Neely M, Day JC, Rheingold SR, Sue PK, Muller WJ, Danziger-Isakov LA, Chu J, Yildirim I, McComsey GA, Frangoul HA, Chen TK, Statler VA, Steinbach WJ, Yin DE, Hamed K, Jones ME, Lademacher C, Desai A, Micklus K, Phillips DL, Kovanda LL, Walsh TJ. Arrieta AC, et al. Among authors: jones me. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0029021. doi: 10.1128/AAC.00290-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34031051 Free PMC article.
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW. Andes DR, et al. Among authors: jones me. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01634-18. doi: 10.1128/AAC.01634-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30373791 Free PMC article. Clinical Trial.
Factors influencing fluoroquinolone resistance.
Sahm DF, Thornsberry C, Jones ME, Karlowsky JA. Sahm DF, et al. Among authors: jones me. Emerg Infect Dis. 2003 Dec;9(12):1651-4. doi: 10.3201/eid0912.030168. Emerg Infect Dis. 2003. PMID: 14725310 Free PMC article. No abstract available.
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Overcash JS, Kim C, Keech R, Gumenchuk I, Ninov B, Gonzalez-Rojas Y, Waters M, Simeonov S, Engelhardt M, Saulay M, Ionescu D, Smart JI, Jones ME, Hamed KA. Overcash JS, et al. Among authors: jones me. Clin Infect Dis. 2021 Oct 5;73(7):e1507-e1517. doi: 10.1093/cid/ciaa974. Clin Infect Dis. 2021. PMID: 32897367 Free PMC article. Clinical Trial.
63 results